(PharmaNewsWire.Com, January 11, 2019 ) Urodynamic study enables physicians in diagnosing causes, and identifying their nature, or detecting dysfunctions in the lower urinary tract. The primary objective of an urodynamic test is understanding disorders/problems occurring in lower urinary tract by duplication of symptoms. Urodynamic study also help in determination of the causes of bladder dysfunction, formulating an appropriate course for the treatment.
According to the World Health Organization (WHO), 330,000 cases of bladder cancer have been diagnosed annually across the globe. In addition, the National Association of Incontinence has estimated 200 Mn people to be affected with urinary incontinence worldwide every year. These incidences have propelled demand for urodynamic devices, owing to rising clinical urgency. A number of healthcare initiatives are being taken for creating awareness about urological problems, along with the availability of treatment and diagnostics for urological disorders. For example, the initiative in Japan - “Let’s Talk and Think About Continence”, and the “Continence Awareness Week” conducted by Continence Foundation in the U.K. These initiatives have deprived people of the social stigma related to these problems, encouraging them to start consulting physicians, which in turn has been augmenting growth of the Global Urodynamic Devices Market.
Moreover, a slew of technological advancements are being observed in urodynamic devices such as penile cuff, intravesical prostatic protrusion, condom catheter, and ultrasound video urodynamic. In addition, other factors such as surging availability of medical reimbursements pertaining to urological preliminary tests, continuous product approvals, and increasing proliferation of network of testing centers are further estimated to fuel demand for urodynamic devices around the world. The global market for urodynamic devices is projected to expand at an impressive CAGR during the forecast period 2017 to 2022, according to a recent research by Fact.MR. The market is estimated to account for revenues worth US$ 265 Mn by 2022-end.
North America will Retain its Dominance in the Global Urodynamic Devices Market
North America will retain its dominance in the global market for urodynamic devices, in terms of revenues. This is primarily attributed to surging prevalence of target diseases in the region, coupled with the robust adoption of urodynamic products in a variety of diagnostic procedures, pharmaceutical as well as healthcare centers, and rising preference of urologists & urogynecologists for urodynamic tests. Asia-Pacific excluding Japan (APEJ) is estimated to be the fastest expanding market for urodynamic devices over the forecast period. This robust expansion of the market in APEJ can be attributed to unmet patient requirements, rising prevalence of urological diseases, and increasing purchasing power of people in the region.
Uroflowmetry urodynamic devices are projected to remain the top-selling device, accounting for over one-fourth revenue share of the market throughout the forecast period. This is mainly because of extensive utilization of uroflowmetry for diagnosis of benign prostatic hypertrophy, prostate cancer, neurogenic bladder, bladder dysfunction, bladder cancer, and urinary blockage. In addition, urodynamic catheters are estimated to be the fastest-selling device in the global urodynamic devices market during 2017 to 2022.
Hospitals will continue to be the largest end-users of urodynamic devices, with sales poised to exceed US$ 150 Mn in revenues by 2022-end. Largest share of the revenues from sales of urodynamic devices in hospitals will be accounted by North America, representing over one-third share of the market. However, sales of urodynamic devices in urology clinics are anticipated to exhibit the highest CAGR through 2022, based on end-users.
Key players participating in the global Urodynamic Devices Market include Albyn Medical Ltd., Boston Scientific Corporation, Medica SpA, Neomedix Systems Pty. Ltd., Dantec Dynamics A/S, CooperSurgical Inc., LABORIE, Verathon Inc., and Best Medical International Inc.
About FactMR FactMR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized market insights reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that's why we publish multi-industry global, regional, and country-specific research reports.
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including: